Adopting Standardized Definitions The Future of Data Collection and Benchmarking in Alternate Site Infusion Must Start Now!

Similar documents
Incorporating Clinical Outcomes. Plan. Barbara S. Prosser, RPh V.P. Clinical Services, Critical Care Systems. Kevin L.

Clarifying Medicare Reimbursement Documentation Requirements: Everything Old is New Again

Adverse Event Reporting

Implementation Guide Version 4.0 Tools

OASIS ITEM ITEM INTENT

Troubleshooting Audio

Agenda: Noon Overview of the regulatory sections affected by the Reform of RoP in Phase 2

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

CAH PREPARATION ON-SITE VISIT

Tools Use Suggested Formats. All facility staff Provides a visual depiction of INTERACT in daily practice

Organization and administration of services

Occupation Description: Responsible for providing nursing care to residents.

Overview of Draft Pharmacovigilance Protocol

2017 Congestive Heart Failure. Program Evaluation. Our mission is to improve the health and quality of life of our members

TITLE: Reporting Adverse Events SOP #: RCO-204 Page: 1 of 5 Effective Date: 01/31/18

CHAPTER 9 PERFORMANCE IMPROVEMENT HOSPITAL

Top 5 Things to Know for CE:

A Case Study in Collaboration: The Delaware Cancer Treatment Task Force. Jerry Ewancio, RPh, Director of Pharmacy, Apple Infusion, Salisbury, MD

Quality Outcomes and Data Collection

ACRIN ADVERSE EVENT REPORTING MANUAL. 1 March 2006 v.3

EVOLENT HEALTH, LLC. Asthma Program Description 2018

Tips and Tools for Selecting an. Grace P. Sierchio-Fletcher MSN, CRNI, CPHQ

A1600 A1800: Most Recent Admission/Entry or Reentry into this Facility

EVOLENT HEALTH, LLC. Heart Failure Program Description 2017

2) The percentage of discharges for which the patient received follow-up within 7 days after

OASIS QUALITY IMPROVEMENT REPORTS

Medication Reconciliation with Pharmacy Technicians

CARE OF THE PATIENT REQUIRING CONTINUOUS FLOLAN INFUSION GUIDELINE

Maggie Turner RN RAC-CT Kara Schilling RN RAC-CT Lisa Gourley RN RAC-CT

Begin Implementation. Train Your Team and Take Action

EVOLENT HEALTH, LLC Diabetes Program Description 2018

State FY2013 Hospital Pay-for-Performance (P4P) Guide

MEASURING POST ACUTE CARE OUTCOMES IN SNFS. David Gifford MD MPH American Health Care Association Atlantic City, NJ Mar 17 th, 2015

Medications: Defining the Role and Responsibility of Physical Therapy Practice

Reducing Preventable Hospital Readmissions in Post Acute Care Kim Barrows RN BSN

CMS Proposed Rule. The IMPACT Act. 3 Overhaul Discharge Planning Processes to Comply With New CoPs. Arlene Maxim VP of Program Development, QIRT

Rhode Island. Phone. Web Site. Licensure Term

Observation Coding and Billing Compliance Montana Hospital Association

FOR LEADINGAGE POST-ACUTE AND LONG TERM SERVICES AND SUPPORTS

Transitioning OPAT (Outpatient Antibiotic Therapy) patients from the Acute Care Setting to the Ambulatory Setting

Leveraging Your Facility s 5 Star Analysis to Improve Quality

Helping physicians care for patients Aider les médecins à prendre soin des patients

Uniform Patient Satisfaction Survey Questions for Home Infusion Providers

Quality ID #46 (NQF 0097): Medication Reconciliation Post-Discharge National Quality Strategy Domain: Communication and Care Coordination

Wisconsin Homecare Organization

PHARMACY SERVICES/MEDICATION USE

What are the potential ethical issues to be considered for the research participants and

FY 2015 IPF PPS Final Rule: USING THE WEBEX Q+A FEATURE

Control Practices for. Mary McGoldrick, MS, RN, CRNI

Enhanced Clinical Workflow Adherence Through Real-Time Alerts and Escalations for P4P

Comparison of Bundled Payment Models. Model 1 Model 2 Model 3 Model 4. hospitals, physicians, and post-acute care where

3/9/2010. Objectives. Pharmacist Role in Medication Safety and Regulatory Compliance

LTCH Lay of the Land: Reporting the LTCH CARE Data Set. July 30, 2012

Administration of Medications A Self-Assessment Guide for Licensed Practical Nurses

The Power of Clinical Callbacks: Preventing Early Readmissions with Clinical Callbacks. Cheryl Crumpton, BSN, RN, CEN

Pediatric Neonatology Sub I

Various Views on Adverse Events: a collection of definitions.

2015 Congestive Heart Failure. Program Evaluation. Our mission is to improve the health and quality of life of our members

NOTE: The first appearance of terms in bold in the body of this document (except titles) are defined terms please refer to the Definitions section.

The Culture of Safety Event Taxonomy: Overview

NEW JERSEY HOSPITAL PERFORMANCE REPORT 2012 DATA PUBLISHED 2015 TECHNICAL REPORT: METHODOLOGY RECOMMENDED CARE (PROCESS OF CARE) MEASURES

CMS s RAI Version 3.0 Manual October 2016

Fairview Pharmacy Services, LLC. Beyond Central Fill: How Central Services Improves Efficiencies and Expands Offerings

MDS Coding. Antipsychotic Quality Measure

Uniform Patient Satisfaction Survey Questions for Home Infusion Providers

Measure #130 (NQF 0419): Documentation of Current Medications in the Medical Record National Quality Strategy Domain: Patient Safety

Final Rule Summary. Medicare Skilled Nursing Facility Prospective Payment System Fiscal Year 2017

3/30/2015. Objectives. Cooking Up a QAPI: Recipe for Success Under the new COPs Part 1

DEMONSTRATED NEED FOR SKILLED CARE FOR MEDICARE PATIENTS: SKILLED NURSING SERVICES

Using MEDMARX for Reporting and Benchmarking. Anne Skinner, RHIA Katherine Jones, PhD, PT

Adopting an All Hazard Approach to Emergency Management Productively Utilizing the National Incident Management System (NIMS)

Quality Improvement: Utilization Measures

PGY1 Oncology 2 Advanced Learning Experience

Version 4 January 18, Principal Investigator: James F. Marion, M.D. The Mount Sinai School of Medicine

Home administration of intravenous diuretics to heart failure patients:

Home Health Value-Based Purchasing Series: HHVBP Model 101. Wednesday, February 3, 2016

Payment Reforms to Improve Care for Patients with Serious Illness

Pharmacy s Role in Decreasing Hospital Readmissions

Patients Own Medications Policy

Session Objectives 10/27/2014. How Can I get Beyond the Basics of Hospital Readmission and Become a Preferred Provider? Kim Barrows RN BSN

Objective Competency Competency Measure To Do List

5 Key Factors to Consider when Selecting a Specialty Pharmacy. A Healthcare Provider s Guide

Session 5: C. difficile LabID Event Analysis for Long-term Care Facilities Using NHSN

EVOLENT HEALTH, LLC. Asthma Program Description 2017

Infusion Therapy from Hospital to Home Bridging the Gap. Lisa A. Gorski RN, MS, HHCNS-BC, CRNI, FAAN

Clinical Guidelines and Performance Measurement

Impact of an Innovative ADC System on Medication Administration

TRANSITIONS of CARE. Francis A. Komara, D.O. Michigan State University College of Osteopathic Medicine

Basic Skills for CAH Quality Managers

Fostering a Culture of Safety

Susan C. Westgate, MSW, LCSWC Inpatient Social Worker, Baltimore, MD

Guidance notes to accompany VTE risk assessment data collection

University of South Carolina. Unanticipated Problems and Adverse Events Guidelines

Study Management SM STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting

Measure #46 (NQF 0097): Medication Reconciliation Post-Discharge National Quality Strategy Domain: Communication and Care Coordination

Medical Management. G.2 At a Glance. G.3 Procedures Requiring Prior Authorization. G.5 How to Contact or Notify Medical Management

PGY1: Pediatric Infectious Diseases Riley Hospital for Children Indiana University Health

Medical Management. G.2 At a Glance. G.2 Procedures Requiring Prior Authorization. G.3 How to Contact or Notify Medical Management

Innovation. Successful Outpatient Management of Kidney Stone Disease. Provider HealthEast Care System

Biomedical IRB MS #

Transcription:

Adopting Standardized Definitions The Future of Data Collection and Benchmarking in Alternate Site Infusion Must Start Now! Connie Sullivan, RPh Infusion Director, Heartland IV Care Lyons, CO

CE Credit in Four Easy Steps! 1. Scan your badge as you enter each session. 2. Carry your Evaluation Packet to every session so you can add session evaluation forms to it. 3. Track your hours on the Statement of Session Attendance Form as you go. 4. At your last session, total the hours and sign both pages of your Statement of Session Attendance Form. Keep the PINK copy for your records. Put the YELLOW and WHITE copies in your CE Envelope. Make sure an Evaluation Form is in your CE Envelope for each session you attended. Miss one? Extras are in a file near Registration. Fill out the information on the outside of the CE Packet envelope, seal it, and drop it in the box near Registration. Applying for Pharmacy CPE? If you have not yet registered for an NABP e-profile ID, please visit www.mycpemonitor.net to do so before submitting your packet. You must enter your NABP e-profile ID in order to receive CE credit this year! 3/29/2013 2

Speaker Disclosures The speaker declares no conflicts of interest or financial interest in any service or product mentioned in this program. Clinical trials and off label/investigational uses will not be discussed during this presentation. 3/29/2013 3

Objectives Review the findings of the Data Definitions Survey Review the different categories of measures that define quality List and describe infusion related outcome measures that are collected today Describe the procedures for implementing a data collection program Map out a procedure for measuring & reporting a sample quality indicator 3/29/2013 4

The Drive to Measure Quality 3/29/2013 5

2012 NHIA Data Definitions Survey Defined the following measures: Hospitalization Reason codes ER Visit ADR Interventions 3/29/2013 6

2012 NHIA Data Definitions Survey Definitions Cont. Catheter infection Status upon Discharge/ Therapy Complete Outcome of hospitalization/ ER Visit/ ADR/ Catheter Event Patient Satisfaction 3/29/2013 7

Hospitalization Definition: An unplanned stay in any acute care facility for more than 23 hours for any reason. All hospitalizations should be counted Hospitalization will be further categorized as related or unrelated to the infusion therapy being provided. 3/29/2013 8

Related Hospitalizations A hospitalization is categorized as related to the infusion therapy if it results from: A catheter event Worsening of the condition for which the infusion therapy is being received An adverse reaction or complication caused by the I.V. medication

Reasons for Hospitalization Standard categories for describing the reasons for hospitalizations related to the infusion therapy are as follows: Catheter infection Catheter event other than infection Worsening of the condition being treated with I.V. therapy Adverse Drug Reaction Infection other than catheter related Change in home environment Unknown

Outcome of Hospitalization The outcome of hospitalization will be categorized as follows: Discharged from I.V. services I.V. services continued without changes I.V. services continued with changes Death

Survey Response for Hospitalization and ER Visit Definitions 98% Agreed with definition 74% Able to report 75% Willing to report 3/29/2013 12

Time Frame for Reporting Hospitalizations Not addressed in definition survey 2 time frames to consider 30 day readmission rate post hospital DC Full I.V. episode 3/29/2013 13

Proposed Definition: Emergency Room Visit Any visit to an acute care facility for immediate treatment resulting in a stay of less than 23 hours, that occurred in an active patient for any reason. Follows same format for related and unrelated as hospitalizations 3/29/2013 14

Adverse Event World Health Organization Definition: "A response to a drug which is noxious and unintended and which occurs at doses normally used in man for prophylaxis, diagnosis, or therapy of disease or for modification of physiological function." (WHO Technical Report 498, 1972) 3/29/2013 15

WHO Classification System Serious: Any adverse event occurring that results in any of the following outcomes: Death, a life threatening adverse event, requires inpatient hospitalization or prolongation of existing hospitalization, a persistent or significant disability/incapacity, or a congenital anomaly/birth defect. Severe: An experience that requires therapeutic intervention. If hospitalization is required for treatment it becomes a serious adverse event. Moderate: An experience that is alleviated with simple therapeutic treatments. Mild: An experience that is usually transient and requires no special treatment or intervention. 3/29/2013 16

Survey Response for ADR 99 100% Agree with definition 90% Able and willing to report 63% Currently use WHO system to categorize ADRs 90% document interventions to ADRs 3/29/2013 17

Discharge Status (Therapy Complete) Applies to any patient who administered all prescribed doses at the time of discharge. Proposed Rules: Rule # 1 Patients count as having completed therapy even if there were interruptions for adverse events, hospitalizations or catheter events. Rule # 2 The designation "Therapy Complete" does not factor in progress toward specific therapy goals or continuation of oral antibiotics after cessation of IV treatment. 3/29/2013 18

Survey Response for Therapy Complete 94% Agreed with definition 80% Able to report 79% Willing to report 3/29/2013 19

Discharge Status Codes DISCHARGE STATUS CODES Total Single Site Multi Site National Death expected 66% 68% 67% 33% Death unexpected 58% 58% 67% 33% Hospitalized 82% 82% 83% 67% Transfer to alternate site/level of care (hospice, SNF, HHA/VNA) 79% 80% 75% 67% Insurance change 58% 58% 58% 67% Lack of adherence 56% 53% 75% 67% Adverse drug reaction 57% 54% 75% 67% Change in home environment/lack of caregiver 43% 41% 50% 67% Loss of IV access 47% 45% 58% 67% Other 27% 26% 33% 33% 3/29/2013 20

Patient Satisfaction More than 80% of providers responded that they ask a same or similar question on their satisfaction survey for most questions 3/29/2013 21

SATISFACTION SURVEY QUESTION SIMILAR SAME TOTAL The medications, equipment and supplies were delivered on time. 12% 79% 91% You would recommend our service to your family and friends. 13% 69% 82% The instructions were adequate to teach you or your caregiver how to give the intravenous (IV) 20% 65% 85% medications. You were satisfied with the overall experience of receiving IV therapy at home. 26% 64% 90% Instruction was adequate for whom to call if you had a problem. The response received to calls for assistance after regular business hours was satisfactory. The services provided met your needs and expectations. You were informed of the possible side effects of the medication you received. The explanation of your financial responsibilities was adequate. 20% 63% 83% 17% 63% 80% 27% 61% 88% 13% 57% 70% 19% 54% 73% 3/29/2013 22

Process Measures Outcome Measures Patient Experience Structural Measures Types of Measures 3/29/2013 23

Infusion Process Measures How well you execute on internal procedures Example: Policy: All PN patients receive a consultation from the dietitian within 72 hours of admission. Measure: % of new PN patients that received an RD assessment within 72 hours of admission 3/29/2013 24

Infusion Outcome Measure Quantifies the results of care Reflects changes in clinical status Example: % Patients who received anti infective therapy that remain infection free for 30 days post EOT % EN patients who are re admitted within 30 days of discharge from the hospital setting 3/29/2013 25

Infusion Patient Experience Measures a patient s satisfaction with the services provided Examples: Would recommend your services to family and friends Agreed the supplies and equipment provided were sufficient to meet needs 3/29/2013 26

Infusion Structural Measures Describe and measure the conditions under which the care is provided Examples: % of patients served by staff vs. contract RN % of patients by catheter type 3/29/2013 27

What NOT to include in an Externally Focused Quality Measure Program Quality measures should reflect patient care This does not include business related indicators such as: Staff turnover rates Employee training practices Length of stay Diagnosis information 3/29/2013 28

Infusion Measures Today Categorize each type of measure: 3/29/2013 29

Answer 3/29/2013 30

Steps for Measuring & Reporting on Quality Indicators Define What? Who? When? Generate the data Retrieve & Validate the data Interpret & Report the data 3/29/2013 31

What to Measure Quality indicator Patient centered Define the value of the service NHIA Data Definitions Re hospitalizations ER Visits ADR Therapy Complete Catheter Complications Patient Satisfaction 3/29/2013 32

Hospice Industry Example Hospice Pain Measure National Quality Forum (NQF) # 0209 Measures the % of patients with pain at initial assessment who report their pain was brought under control within 48 hours 3/29/2013 33

Hospice Quality Measure Cont. First quality measure for hospice All hospices required to report data from Q4, 2012 or have 2014 payments reduced No standardized data collection tool Tool developed by SHP for their customers Submission deadline is April 1, 2013 3/29/2013 34

Defining the Denominator = Who WHO should be measured? Describe the patient population eligible for the measure Hospice Example: All new hospice admissions Any patient who can self report pain Patients 18+ years old Able to communicate and understand the language of the person asking the assessment questions 3/29/2013 35

When to Measure Define the time frame for generating the data May exceed dates of service 30 day hospital re admissions IVAB Relapse rates Hospice Example: Q4 2012 data due 4/1/13 3/29/2013 36

Data sources: Generate the Data EMR Paper patient records Incident reports Specific data collection tool or worksheet Satisfaction surveys 3/29/2013 37

Hospice Pain Data Collection Tool 3/29/2013 38

Hospice Example Method Admitting RN will generate the data during the first home visit Verify eligibility Ask initial question Develop a tracking process for patients needing follow up in 48 72 hours 48 hour follow up question will be asked during a home visit or via phone call by hospice case manager 3/29/2013 39

Retrieve the Data Electronic extraction reports Identify eligible patients Patient/indicator specific data Collection of paper worksheets Review for accuracy Do the responses make sense? Missing data? Employee errors? 3/29/2013 40

Validate Compare number of reports to total patients eligible Spot audits Chart reviews Patient interviews Employee interviews Compare documentation & results from different sites/ employees 3/29/2013 41

Aggregate the Data Determine what data elements need to be counted/quantified Determine the source for each piece of data 3/29/2013 42

Good Advice Not all things that can be counted matter, and everything that matters cannot always be counted. Albert Einstein 3/29/2013 43

Hospice Measure Example Data Elements to Aggregate & the Source: # of patients (18 years or order) admitted during the measurement time frame (EMR billing system) # patients that were eligible (Worksheet) # patients that answered no to Q 1 (Worksheet) # patients that answered yes to Q 1 (Worksheet) # patients eligible for 48 hour follow up question (Manual Spreadsheet) # patients that answered no to Q 2 (Worksheet) # patients that answered yes to Q 2 (Worksheet) 3/29/2013 44

Hospice Example Cont. Denominator Calculation: # Patients with pain at initial assessment + any missing Identifies patients that must be followed for 48 hour follow up question 3/29/2013 45

Hospice Example Cont. Numerator Calculation # Patients that answered yes to the 48 hour follow up question Reported as % of patients with pain at initial assessment who report pain was under control within 48 hours. 3/29/2013 46

Figure 3. NQF #0209 Data Collection Process

Review 1. Define the measure 2. Define the population (denominator) 3. Define the time frame 4. Develop a data generation process 5. Develop a procedure for validation 6. Aggregate, Validate and Report 3/29/2013 48

Workshop Work with a partner Identify a patient centered quality measure to map Demonstration measure: 30 day hospital re admission rates 3/29/2013 49

Step 1: Identify a Quality Measure Choose from one of the following: Process Measure Structural Measure Patient Satisfaction Outcome Measure 3/29/2013 50

Step 1. Selecting a Quality Measure Is the measure Patient Care Related? Does it address one of the following areas? Symptom management Care coordination Safety Change in clinical status Satisfaction 3/29/2013 51

Example Measures % of patients re hospitalized within 30 days of hospital DC (demo) % of patients that experience an ADR % of patients achieving independence with selfadministration of I.V. therapy % of patients who complete therapy as prescribed % of patients that require a catheter de clotting procedure % of patients receiving a medication profile review within 72 hours of admission 3/29/2013 52

Step 2: Describe the Population Who is eligible to be measured? Any special characteristics that need to be considered? Site of care variations? How will the population be identified? Will you exclude any patients? Why? 3/29/2013 53

Sample Measure Population % of patients re hospitalized within 30 days of hospital DC All patients admitted to service that are discharged from the hospital setting Additional considerations? Limit to single hospital provider? Limit by therapy type? Limit by payer? Any populations that need to be excluded? 3/29/2013 54

Re hospitalization Rate Example For this example we will look at all nonhospice patients discharged from the hospital setting admitted for IVAB and nutrition support therapies Data will be aggregated by age <65 years 65 + years 3/29/2013 55

Source of Population Data Describe the source that will provide the full list of eligible patients to be measured Electronic Report Admissions Reports 30 day Re admission Rate Example: Rockpond report from CPR Plus Will identify all non hospice patients who were admitted to service from the hospital setting 3/29/2013 56

CPR Source Population Report 3/29/2013 57

Step 3. Identify the Time Frames Define the reporting time period Usually monthly or quarterly Set targets for reporting each measurement period April 1 for Q4, 2012 Consider the source and quantity of data How much time is needed to validate and aggregate? 3/29/2013 58

Step 4. Describe the Data Collection Tools Electronic fields Unique data field User defined Minimize free text Standardization is key! Worksheet tools Electronic v. Manual Minimize writing 3/29/2013 59

30 Day Re admission Example 3/29/2013 60

Data Collection Tips Aim for in the moment documentation Avoid stock piling data to enter after the fact Electronic prompts/reminders Visual reminders Employee training is KEY! 3/29/2013 61

Step 5. Aggregate the Data List the data elements to be collected Develop a tool for summarizing the data 30 Day Re admission Rates Example: # Eligible Patients Hospital DC date Therapy Type Age # Re hospitalized within 30 days 3/29/2013 62

Sample Data Aggregation Tool 3/29/2013 63

Step 6. Validate Identify methods for validation Compare reports from different sources Chart audits 30 Day Re admission Rate Example Compare Hospital Assessments to Hospitalization Progress Notes entered Review patients with billing gaps 3/29/2013 64

Step 7. Report Identify how the data will be used? QI Sales efforts Operations Benchmarking Who is the audience for your data? 3/29/2013 65

30 Day Re admission Rate Example 3/29/2013 66

Report your results Internal v. external Reporting Benefits of internal reporting Creates ownership Generates new ideas Improves quality & efficiency Identify & overcome barriers 3/29/2013 67

Audience Presentations 3/29/2013 68

Wrap Up 1. Adopt the NHIA standard definitions www.nhia.org/data 2. Get started! Identify SOMETHING you can measure NOW!! Look for data opportunities that create value for your organization 3. Evaluate data collection methods Electronic, Standardize, Minimize 4. Aggregate, Validate and Report your data 3/29/2013 69